Madrigal Pharmaceuticals, Inc. (MDGL)
MDGL Stock Chart More Charts
MDGL Price/Volume Stats
| Current price | $143.72 |
| Prev. close | $146.23 |
| Day low | $121.99 |
| Day high | $153.60 |
| 50-day MA | $203.25 |
| 200-day MA | $192.97 |
| 52-week high | $325.98 |
| 52-week low | $38.82 |
| Volume | 1,144,900 |
| Avg. volume | 279,731 |
| Dividend yield | N/A |
| Market Cap | 2.21B |
MDGL Returns
| 1-mo | -24.03% |
| 3-mo | -39.68% |
| 6-mo | 8.90% |
| 1-year | 245.15% |
| 3-year | 854.95% |
| 5-year | -2.92% |
| YTD | 56.57% |
| 2017 | 516.04% |
| 2016 | 21.63% |
| 2015 | -86.79% |
| 2014 | -49.43% |
| 2013 | -41.91% |
Madrigal Pharmaceuticals, Inc. (MDGL) Company Bio
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of cardiovascular, metabolic, and liver diseases. The company was founded in 2011 and is based in Fort Washington, Pennsylvania.
Loading social stream, please wait...